Otros idiomas Novo Nordisk A/S Mexican S.E.

Acciones

NVO N

US6701002056

Precio de cierre Mexican S.E. Otros sitios de cotización 00:00:00 05/07/2024			Varia. Cinco días.	Varia. 1 de enero.
2.578 ^MXN	+2,39 %		-2,01 %	+46,69 %

10:36	Eli Lilly y Novo Holdings participan en la ronda de financiación de 114 millones de dólares de Myricx Bio	MT
05/07	Pacientes con diabetes que toman GLP-1 en lugar de insulina tienen menor riesgo de cáncer: estudio	RE

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Un traitement d'Eli Lilly permet de perdre davantage de poids qu'Ozempic	18:25
Tirzepatid oder Semaglutid - Was lässt mehr Gewicht verlieren?	17:05
Novo Nordisk A/S - share repurchase programme	15:19
Eli Lilly, Novo Holdings Participate in Myricx Bio's $114 Million Financing Round	10:36
Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code	05/07
Ambu A/S: innovatieve leider in medische wegwerpartikelen	05/07
UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches	05/07
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading	05/07
Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector	05/07
ETF der Woche: Starke Trends mit Momentum	05/07
L'ETF della settimana: investire in trend forti con il tema del momentum	05/07
ETF van de week: beleggen in sterke trends met de momentumfactor	04/07
ETF of the week: Investing in strong trends with the momentum theme	04/07
ETF de la semaine : Investir sur les tendances fortes avec la thématique du momentum	04/07
En Direct des Marchés : Sanofi, TotalEnergies, Airbus, Eramet, Dassaut Systèmes, KKR, Ford...	04/07
Des marchés infatigables	04/07
Borsa di Italia: Mercati instancabili	04/07
Sector Update: Health Care Stocks Fall in Afternoon Trading	03/07
Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows	03/07
Top Midday Stories: Southwest Board Approves Shareholder Rights Plan; National Amusements Agrees to Preliminary Deal to Sell Paramount to Skydance; Ozempic, Wegovy Linked to Blinding Eye Condition, Study Says	03/07